Bioventix PLC (AIM: BVXP)
3,975.00
+25.00 (0.63%)
Sep 10, 2024, 3:42 PM GMT+1
Bioventix Company Description
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Bioventix PLC
Country | United Kingdom |
Founded | 2003 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 12 |
CEO | Peter Harrison |
Contact Details
Address: 7 Romans Business Park Farnham, GU9 7SX United Kingdom | |
Phone | 44 12 5272 8001 |
Website | bioventix.com |
Stock Details
Ticker Symbol | BVXP |
Exchange | London Stock Exchange AIM |
Fiscal Year | July - June |
Reporting Currency | GBP |
ISIN Number | GB00B4QVDF07 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Peter Harrison | Chief Executive Officer |
Bruce Edward Hiscock | Chief Financial Officer |